menu search

Calyxt, Inc. Reports its Fourth Quarter 2022 Financial Results and Provides Corporate Update

Calyxt, Inc. Reports its Fourth Quarter 2022 Financial Results and Provides Corporate Update
NEW YORK, March 06, 2023 (GLOBE NEWSWIRE) — Cellectis S.A. (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company for which Cellectis owns 49.1% (as of December 31, 2022) of […] The post Calyxt, Inc. Reports its Fourth Quarter 2022 Financial Results and Provides Corporate Update appeared first... Read More
Posted: Mar 6 2023, 21:30
Author Name: forextv
Views: 082166

Search within

Pages Search Results: